3 completed, 2 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow TEV-50717: new trials by email Literature Review of TEV-50717 trials Research Report on TEV-50717
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy TEV-50717 - Cerebral Palsy, Dyskinetic | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 44 | 2020-02-04 | 2024-04-22 |
| A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents TEV-50717, Placebo - Cerebral Palsy, Dyskinetic | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 63 | 2019-08-06 | 2023-09-08 |
| A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) TEV-50717, Placebo - Tourette Syndrome | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 158 | 2018-05-31 | 2021-11-09 |
| Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents TEV-50717, Placebo - Tourette Syndrome | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 228 | 2018-05-25 | 2021-11-09 |
| Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents TEV-50717, Placebo - Tourette Syndrome | Phase 2 / Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 119 | 2018-02-05 | 2021-11-09 |
Tourette Syndrome (3) · Cerebral Palsy (2)
Teva Branded Pharmaceutical Products R&D, Inc. (5)
United States (5) · Denmark (4) · Italy (4) · Poland (4) · Russia (4) · Spain (4) · Ukraine (4) · Canada (3) · Argentina (2) · Australia (2) · Colombia (2) · Hungary (2) · Israel (2) · Mexico (2) · Serbia (2)
2016 (2), 2017 (1), 2018 (1), 2019 (1)